Skip to main
ISRG

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 15%
Buy 54%
Hold 23%
Sell 0%
Strong Sell 8%

Bulls say

Intuitive Surgical has demonstrated robust growth in its Ion and SP system installations, with Ion utilization rising by 14% and SP utilization increasing by 35%, contributing to an expanding installed base that underscores the company’s market penetration. The improvement in gross margin guidance to 67-67.5% due to higher US system placements and favorable tariff outlook highlights Intuitive Surgical's operational efficiency and profitability potential. Additionally, the increasing Da Vinci system utilization, particularly driven by the adoption of the D5 model among surgeons, suggests a positive trend in procedural growth, reinforcing the company's strong market position.

Bears say

Intuitive Surgical's recent financial performance indicates several challenges that contribute to a negative outlook on its stock. Revenue from services was slightly below expectations at $396 million, and there is significant concern about the impact of macroeconomic factors on hospital capital budgets, which could restrain future robotic system purchases. Additionally, the company faces ongoing resistance from markets and physicians towards adopting newer robotic surgical technologies, combined with a prolonged rollout of next-generation systems and issues related to third-party instrument reprocessing affecting consumable sales.

Intuitive Surgical (ISRG) has been analyzed by 13 analysts, with a consensus rating of Buy. 15% of analysts recommend a Strong Buy, 54% recommend Buy, 23% suggest Holding, 0% advise Selling, and 8% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 13 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $593.23, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $593.23, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.